CA2119787A1 - Softgel manufacturing process - Google Patents
Softgel manufacturing processInfo
- Publication number
- CA2119787A1 CA2119787A1 CA002119787A CA2119787A CA2119787A1 CA 2119787 A1 CA2119787 A1 CA 2119787A1 CA 002119787 A CA002119787 A CA 002119787A CA 2119787 A CA2119787 A CA 2119787A CA 2119787 A1 CA2119787 A1 CA 2119787A1
- Authority
- CA
- Canada
- Prior art keywords
- process according
- shell
- stress relieving
- softgels
- fill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- 238000001035 drying Methods 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims description 33
- 230000008569 process Effects 0.000 claims description 29
- 239000002775 capsule Substances 0.000 claims description 25
- 108010010803 Gelatin Proteins 0.000 claims description 14
- 229920000159 gelatin Polymers 0.000 claims description 14
- 235000019322 gelatine Nutrition 0.000 claims description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000008273 gelatin Substances 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 5
- 230000007547 defect Effects 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 230000000977 initiatory effect Effects 0.000 claims 1
- 230000035882 stress Effects 0.000 description 16
- 150000002500 ions Chemical class 0.000 description 10
- 238000005496 tempering Methods 0.000 description 10
- 239000000499 gel Substances 0.000 description 7
- 241000905957 Channa melasoma Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000006696 Catha edulis Nutrition 0.000 description 1
- 240000007681 Catha edulis Species 0.000 description 1
- DSEKYWAQQVUQTP-UHFFFAOYSA-N Cerin Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CC(O)C(=O)C2C DSEKYWAQQVUQTP-UHFFFAOYSA-N 0.000 description 1
- 241000543381 Cliftonia monophylla Species 0.000 description 1
- 101150083807 HSD17B10 gene Proteins 0.000 description 1
- 241000353097 Molva molva Species 0.000 description 1
- 241001131927 Placea Species 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000193803 Therea Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 208000029618 autoimmune pulmonary alveolar proteinosis Diseases 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 101150083127 brox gene Proteins 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- KOWWOODYPWDWOJ-LVBPXUMQSA-N elatine Chemical compound C([C@]12CN(C3[C@@]45OCO[C@]44[C@H]6[C@@H](OC)[C@@H]([C@H](C4)OC)C[C@H]6[C@@]3([C@@H]1[C@@H]5OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N1C(=O)CC(C)C1=O KOWWOODYPWDWOJ-LVBPXUMQSA-N 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- VJZLQIPZNBPASX-OJJGEMKLSA-L prednisolone sodium phosphate Chemical compound [Na+].[Na+].O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COP([O-])([O-])=O)[C@@H]4[C@@H]3CCC2=C1 VJZLQIPZNBPASX-OJJGEMKLSA-L 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940030186 xpect Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
Abstract
After softgels are encapsulated and dried in a drying tunnel, the resulting softgels are subjected to a further stress relieving step. During the stress relieving step, the temperature and humidity conditions in the drying tunnel are heightened. By utilizing the stress relieving step, the volume and number of dimples and bubbles in the softgels are reduced, and dimensional uniformity is maximized.
Description
,. W093/04674 2 i ~ ~ 7 ~ 7 PCT/U~92/07487 1 ,.
SOFTGEL MANUFA~TURING PROCESS
1. Field of the Invention This inven~ion relates generally to the field of pharmaceutical manu~acturing proce~ses and ~pecifiaally to the ~ield of softgel manufacturing processe~.
SOFTGEL MANUFA~TURING PROCESS
1. Field of the Invention This inven~ion relates generally to the field of pharmaceutical manu~acturing proce~ses and ~pecifiaally to the ~ield of softgel manufacturing processe~.
2. Rel~d ~r~
l~he need ~or ~ncapsulation o~ liguids, ~smi-601i~, 10 and pa~tes within a gelatin shell in su¢h a way as to preclude uncontrolle~ leakage ha~ resultea in the developmsnt of a ~ery fundamental dosage form: ~he so~t g~latin capsule. ~he ~irs~ ~ersion was developed in the middle o~ the l9th cent~ry~ While an ardu~us and no~ particularly accurate proce~s lnitially, current manu~acturi~g proc~sses are fully automated, with a high de~ree o~ prea~sion~
Th~ softgel ~the currently acaepted nom~nclature ~: . adopted by the So~tGel ~ssociation~ is a one-piece~
2:0 . hermetica:lly sealod soft gel~ati~ shell containing a liquid, a suspension, or a ~emi-solid. Y
The mos~ common modern manu~act~rîng process involved in th~ p~paration~of so~tgels is a~aantinuous : methiod whereby two gelatin r~b~ons pa~s ~etween twin 25: : rotating dies. As th~ ribbons m~et, the l~quid to ~e ncapsulatea is~pr~cisely:injected betwe~n ~hem. The : capæule hal~es~are seal~d~and~e~e~ted by the eiontinuous ~; rotation of the::dies. See~P.;Tyle/ SPecialized Druq : DeliverY SYste~s,:;Narcel:Dekker, Inc. (~g90). for a ` 30 genera~l discussion~:of softgel manufac*uring`and : prod~ction~techn~logy, in:~particular, Chapt~r 10 by ~:~: Paul ~.;Wilkinaon~and Foo;~Song Hom.
Various ge~atin:s~ell~masses~may~be prepared, `~` depending on the ~ill proper~ies, climatici condi~ions, 35 ~ and en uGe. Typically gelatin~formulations include the came basic~ingredien~s,~:namely,~ gelatin, a :
5~TITI~T~ FT
1~'JO 93/04674 2 i 1 ~ 7 8 7 Pcr/~sg~/~748 2 r pla;tici~er such as glycerin" water, ana optionally pre~ :e:r~ratives . The formulations of gelatins are well lcnown to those of ordinary sXill in the art.
:t:n most cases, the typica~ rotary dle proces.
,,~
5 requires a ~lowable liguid or f ill . The f ill may be a ~;ingle phas~ uid ac~i~e, a mi~ure of mi~scible liguidcr or a ~ol~ion or a ~uspension o~ ~olids and li~Euids. ~;enerall~ ~e fill contain g~cerin ~nd a medicamellt~ The liquids to be encapsula*ed in a 10 g~l~tin ghell are a~so well l~nc)wn to tho~e af ordinar~
skill in the art.
Shell and flll formulations are dis.cussed in Van Hostetler and J.Q. Bella~d no~ed below as w811 21S in "~d~rances in So~tgel Form~ation ~echnology", I~.S.
~ P~tel, F~S~rS~I Morton a~d~I. S.eager, N~nu~acturing Chemists,. July ~9~9; "So~ Elastic Gela~in Capsules:
~n~que Dosage ~orm", William R~: Ebert, P~armaceutical Techn~logy~ October 1977; "So~t gelatin capsules: a : 601ution to ma~ ~able~ng problems", H. Seager, 20 Pharmaceutical Techno~ogy, Sep~mber 1985; United ; Sta~s Pate~t Na. 4,06.7,960 to Fadda; Un~ted S~ates Pa~ent No. 4,198,3~1 to Grai~ger; Uni~ed S~ates Pa~e~t No. 4r~44r~8~. to ~ro~; and United States Patent No.
780r316 to Brox.~ ~hese re~erences are ~naorporated :2~ . herein b~ this referen~e~
ter the rDtary d~e~pr~ces~s is used ~o thereby : produ~ge~a~n~she~ s~hàvin~ ~ medicam~n~ fil~
therein, the resul~n~ capsules are typically washed wit~ an evaporatable solvent.~ ~hereaPter, the ¢apsules are t~pically tumble~drie~:in ~ series o~ hollow drum5 wi~h`perforate~ wa~ls- Hea~ed dr~ air i5 con~inuously : p~mpe~ throug~ ~he~rotating drums at an air tem~erature : typiaally l~ss than:35C.~ T~e war~1r being blown into:~e aapsules~appear~ :penetrate ~e shell a~d cauæe~t to dry from the ~nside by~m:o~ing t~e water ~: outward to the surfaae of the~capsule. By the time t~e : capsules exi~ this`process, all of the ~olvent used in . . :
:
:
~ ,W093/04674 2 ~ 1 ~ 7 8 7 PCT/VS92/07487 3.
washing has typically been evaporated, and a large proportion (50-60%) of the water from the gelatin shell haq ~een removed. Recent developments in drying include bypa~sing ~he drum drying stag~ and having the aapsules dried in a drying tunnel or room as discuss~d below~
After the capsules exit the la~t drying drum, the aapsules are typically ~pread on drying trays. The ~inal drying pha~ ~or softyels is ~ypically acc~mplished ~.,pa~sing the drying trays through drying tunnels or in~o drying rooms~ Stacks o~ trays are inserted ~nto drying tunnels or drying ro~m~, in which controlled temperatur~ air ~21-24~C~ ~nd 1QW relative humidity ~20-30%) i~ continuously circul~ted. Although additional water may ~e remo~ed ~rom dxy capsules by further heating, ~or example a~ 40C, such a procedure has not been found to b~ prac~iaal or necessary. See Van ~05t~tler and J.Q. Bellard in The ~heory and Practice o~ Industrlal Pharmacy, "Capsules~', (1970), Chapter ~3 at pa~s 346-383, and in particular at page 380.
: The drying time, for most softgel~, is 16-24 hours, but may be slightly longex i~ the qo~tgels arç over 20 minims in ~ize or i~ the 50~tg~1s contain a non-o~ly typ~ liquid base.
Softgels per~itted ta~ come to water equilib~ium in this aontrolIéd enviror~snt are considered "dry". ~rhe gQlatin f ~11 and shell of suc~ "dry" sof~gels con~ain 6-10% wa~er depending on the ~pecific ~elatin and fill 30 f~rmula used.
' I P~fter q:rying, t:he capsules areitypically insp cted and ~inished using varied lcnown tec:hni~ues.
~ ' ~
:: 3. The Proklem~and Obiects o~ the ~nvention ~5 D~spite well known manu~acturing proc~sses for softgels, a nu~ber of significant problems exist.
During the inspection step, it is yuite common to ~ind ` : :
~?VO g3/04674 2 :~ 1 9 7 8 7 PCI/US92/07487 4.
so:~tgels ha~ring dimples in the shell and bubbles in the I~ill. q?he dimples and bubbles are unsightly in appearance and reduce the o~rerall quali~y o~.the 50ft~el batch. Thus those de~ect~ ve ~30ftgel~ must be 5 rej ected or thro~ away ~. Cor~se~uent~ as a resul-t o:e ~;uc:h ~ples and bubbles, softgel pro~uct:ion ef$ic:ien~y is decreased~
Moreo~e:r it is highly desired that the sc?f~ge manufacturing proc~sE~ result in a batch of~
10 dimensicnally uni~or~ so~gel~. ~pically uni~ormity o~ a softgel i8 measured by the standard dev~atlon in ~e ~enç~thwise and wid~hwise measurement o~ an oblong $o~tgel or th~ diameter o~ a r~nd sof~gel. ~lthough atte~pts have been made to produce more dimensioIlally 15 un~orm prod:u¢ts, for example, produa~s having a reduced dimensional s*andard d~iation, 130ftgels prot~uced a~ter typ~ca~ drying processes often result in an unacaepta~le standard deviation.
It is thereore an object o~ the present inven~ion ~0 to pro~ide a 50f~g~1 manufacturing process which results i~ softgel products having a minimal ~olume and num~er of dimples;and bukbles, and w~ic~ ~re rela~ively aimensionally:unifonm~
~:~ 2~ ~pNakY OF ~HE D ~ SURE
Th~ pro~ems of di~ples, ~ubble~ and pr~duct d ~e~sion~l uniformity ~a~e~been greatly reduc~d by the present invention ~hich~is a ~igni~icant advance in ~he art of so~tgeI~;ma~facturing:proce~ . The inventors ~a~Q di~cov~ere~ at by~sub~e~ting '~dry'l ~o~gel~ to ~
' subs~guent1~*ress rellcving step, the volume ana number : of defects s~h~as dimp1es~and bubb}es exi~ting în ~he : sof~gQ~s pr~or:to the stress rel~e~ing step can be su~s~an~ially ~educ~d. In addikion, the stress ~ 35 relie~ing st~p;reduGes dimensional s~andard de~ia~ion : ther~by resulting in more~dimensionally unifo~m batGhes of softgels~ ~
:~ .
W093/0~674 2 1 1 ~ 7 8 7 PCT/US92J07487 ~. , The stress relie~ing step comprises subjecting the "dry" capsules to a subsequent heating step at a heightened temperature and relati~e humidîty. By subjecting the "dry" softgels to this step, dimpl~s and ~ubbles ~re removed ~rom the softgels and the dimensional standard deviation is pre~erably reduced.
Brie~ ~escri~tion o~_the Fiqures Fig. 1 is a schemati~ ~howing the s~ress r~lieving or tempering room.
Figs~ 2~ and B are ~f~r~ and a~ter phatograph~ of o~tgels sub~ected to th~ str~s5 relieving ~kep.
~, DET~LIIJED DESC~IPTION OF TH~ ~EF~D EMsoDIMENq!s Sc)ftgel~; are genQrally prep~r2d 3~y enc~psNl~ting a medicated f ill in a gelatin shell .. The shells and fills are pr~pared acaording to go~mulations w~ll known to those o~ skill in the art. For example, a typical gelatin shell formulation might inGlude ~by weight):
Gelatin 47%
:~ Glycerin, USP~ 15%
Water 38%
+ Colors~
. .
~he shell oan be ~illed by ~tandard encapsulation teahniques with a variety~:of ills including PEG and propylene glycol. ~ ~
30 ~ A~ypical hygroscopic medicated fill might include ! ' ' (by weight)~
` ~ : :; `
ACTIVES: ~Acetaminoph~n (APAP) (250 mg~ 27~
~ P~eudoephedrin HCl (30 mg) 3%
: 35 Dextromethoxphan~Br ~15 mg) 1.6%
Doxylamine Succinat~ (6.25 mg) .6%
; X~ACTIVE: Polyethylene Glycol (PEG) 67.8 :
:: :
wo g3/04674 ~ 7 ~ 7 PCI/US92/07487 6.
Although the example above uses a hydrophilic f ill, other ~ill5 are within the æcope of the pre~;ent in~re~on. Tn addition, the P}~G can be PEG 400 or a PEG of higher molecul~ar weight. Eurther, th~ use of 5 sorbitol ~ree shell~; appear~ to facilitate the st:ress relieving ~:tep.
~ rhe softgelt; can be encapsulate~l using known fill~
and shell~; by t~chTligues kno~m to thos~ o~ ~kill in the art, for ex~mp Q~ eithe~ t~e plate method or ~he 10 con~inuous rotati~ die methods ~e~cribed pre~iousl~.
~ ter the encapsulatioll and wash~ng steps, the resultlng capsules are typically dried ~n drying tunnels or rooms for.2tbc~ut 3-7 da~Ts ~o remove ~a~er in the hys~roscopic fill and the shell to abou~ 6~% by 15 volume.. ~hese are t~ ally call~d "d:ry" capsules.
T~e g~rl Fischçr tes~ is used for determinirlg water content~ Th~ drying oc:curs t~ically at about 21~-249C
and at a rela*i~re h~m;idity o~ 20-~0%. One can llse infrared rad~at:ios~ ~o dr~ ou~ the wate~ as an 2.0 alternati~re.
~ e amolmt o~ time the capsules are in the drying ~unnels or room depends o~ t~e thickness of the gala~in shell, ~he a~ount o~ oll o~ the surface of the gel after t~e ~ashin~ st~, tb,e :densi~y o~ .capsules on the 2$ trays~ and other fac~Drs. kTwwn to ~hose of ordinary sJ~i~l in th~ art.
A~er t~e cap~sules ar~ t they are sub~e-c~ed ~o the nov~l step of t~e presen~ inve:~tion, namely a stress relieving step.
~he s~ress relieving step is als~ referred ~o hereln as a su~se~uent h~a~in~{ step or a ~empering step . In general ,: the stress relieving step lnvolves a change in th~ conai~:ions o~temperature and relati~re humidit~ f~rom ~he drying ;step.~ By changing the condit~ons of ~emperature~ and relative humidity, dimpl~s in the shell ~nd bub~les i~ the fill are .
... W093/04~74 . 2 1 1 9 7 8 7 PCT/US92~07487 7.
substantially removed. In addition, the product preferab~y becomes more dimensionally uniform.
The stre~ relieving ~tep can take plae in the same tunnel's or drying rooms or tempering rooms as the priox drying s~ep, and thus no new eguipment or additional labor is required. ~oreover, the stress relie~ing step can-be ~caomplished in the continuum o~
the d~ing st~p. For example, cap~ules could be dried ~or three day5 in drying tunnels and ~ubsequently ~0 8tre~s relieved with elevated temperature an~ humidity conditicns~ In suah case, the bubbles and dimples would not be o~erv~d. ~hi~ is due to the fact that drying continues during the time period that the p~oduct is in the tempering room.
With re~er2nce to Figure 1, there is shown in block layout ~orm an iIlustrativ~ and pre~erred air conditioning sy8tem for inspection rooms 10 and a tempering room 20 whi~h can selectively maintain 21~
43~ and 35-60% rel~ti~e humldity. The tempering r~om can be used ~or the~.drying and:s~ress relie~ing steps.
As can be seen fr~m th~ block layout there is one : 7~ ton heat pump 30 with a second unit (not shown) as a back up, a humidi~ier 40, two l~KW duct strip heaters 50, and one 15KW: ~uct heatex 60 for supplying air to eacll room. Also th~ te~pering room 20 has six 3000 CE~
blower fans 70 mounted at one end o~ the tempering room for circulating ~room air and a filter banlc e~aust (not shown) at the ol?posite: ~nd of the room. Each room is also supplied with ia temperature thermostat (no~ shown) that control~ the~duct ~trip ;hea~ers. There i~; a humidistat l(nc~t shown) mounted in the tempering room which controls the humidifie~ 40.
~he degree ~o:which:de~ects such as dimples i~nd bubbl~s are remo~ed can be mea~ured by considering the :35 number and v~lume of dimples and bubbles prior to the : stress r~lie~ing step as~compared to the number and volume foll~win~ the stress relieving ~tep. Figures 2A
~ W~ ~3/04674 2 1 ~ .~ 7 ~ 7 PC~/US9~/074~7 8.
and B axe photographs of a ba~ch of softgels before the ~tress relieving or tPmpering step and therea~ter.
Th~ so:~gel capsules shown had the following formulati~n (l~y we~ght):
Shell: Gelatin 47%
Giyaerin 15%
Water 3~ (plus color~ng agent and be~s:)re dr~,ring S~QP) Fill: PQ~ hY1ene Gl~col ~Q0% (920 mg) One hundxed capsules were placea on a coun~ing tray 15 after l:eiTIg me2Lsu:~ed indivi~all~"rc The~3e c~psules were preY~ousl~ dried ~Eor nine days to a water c~nten~ ":e 7.9% under cond~ions of 27.~ rela~i~e hum~d:3~y a~sd 24C
to thereby conq~i~u~e "d~y" softgels.
As i~dicated ~by t:he before pho~o~raph: in Fig~re 2A;, ;20 all of the capsules con~ained bubble~. The~e capsul~s wsre ~:tres5 r~lie~ea at 35C and 45% rela~ive humidity for 20 hou~s, and: then re-photograph~sd as sho~n in Figure 2~. As c~n l~e séen~ all ~ubbles ~l~h ~he exca~ on oi~ two were ~liminated and the d~ensional 2~$ ~aria~n of the cap~ul es wa~ re~d. That iF;, k~e s~andard d~ation of 'che length was reducea ~rom Q.t~0458 i~o 0.û-042~ inch~s and o~ ~:he ~i~th :~ro~ 0.0036 to 0 . 0033 ~ hes ~ : .
~hese $ame capsul~s were returned to ~he tempering 30 room i~or an ~ddi~ional 20; hours~ Af~r the second tempering:, no bu~bles~ remained.
q~he pr~:3e~t inven~ t~nded ~o decrea5e -~he vol~e o ~limples and: bubbles b~ at least preferabl~ by 5096, more pre~er~ly ~y at l~ast 75%, an~
35 opti:mally b~ 9~ 0%~ ~rhe decr2ase in ~i~ples and bubbles can readily be ~isually saen during ~nspection ' ' ~ .
, ,. ,,wo g3/04674 Pcr/vss2/074g7 of the softgels before and after the ~tress xelieving step .
Generally, the stres~ relieving step is accompli~hed at a temperature within the preferred range of 32 and 38~C. It is possible to ~tres~
relieve the capsule~ at a temperature above ~3C
depending upon the fill and gelatin formula~ The temperature should not be so hi~h such khat the capsules w~uld melt. 43C is generally at the high end, although preferably the high end i~ 3BC.
On ~he other hand, the temp~rature range at the low end i5 pre~erably a~o~t 35C~ I~ the tempera~ure is.
much lower than 35ac, the ~tress relie~ing may not b~
adequate or else the stress relieving step may ta~e an undesirable and impractical length of time.
Thu~, in general, it is pre~erable that the temperature of the drying tunnel~ or drying rooms during the stress relieving~step range fxom ~o to 43C, and more pre~erably from 35 to 38C.
Dur~ng the ~tre~ reli~ving step,.it is also important that the relative humidity within the tunn~ls or te~pering room xange ~rom about 35~ ~o a~out 60%, preferably 35-4~5%, and optimall~ 40-45%. Employin~
this relative hu~idity range, coupled with the heightened tempe~ature, un~xpect~dly provides ~o so~tgel batches ~he long needed increase in topological ~ ana dimensional uniformity.
: The hum~d~ty range is m~an~ to match th~
equilibrium relati~e humidity (E~H) of the ~apsules.
I~ the tunnel or tempering room relative humidity is .. below 35%/ exaessive drying~may ocour. If the relati~e humidity is abo~e 60%,:water may b~e added t~ the gelatin and fill~ resulting in a poor product.
From a gener~l standpoint, the stress relieYing æt~p wiIl be at that~temperature, relati~e humi~ity and for that time period:tbat will remove substantiall~ all ~ 93J0~674 2 1 ~ 7 ~ 7 PCr/US92/07487 10 .
dimples and ~u~bles, and pr~erably tha~ will minimize dlmen~;ional ~;tar~dard deviation.
Generally, the str~ss relieving step will take at least one h~ur, p~e:erab~ at least two hours. The general rang~ is about 1 ~o 7S hours, although over 75 hours is wi~hin t~e s~ope o~ the present invention.
q!he process of ~:he present in~ention i~ also charac~exizea by ~proving the consistency or ~i~o~mi~y of t:~e softgel~ and reducing. the stand~rd de~riation of ~e softgel dim~nsions. When c~?mpa~ing the standard dev~:a~ion o~ the soft~el d~mensions.
(leng~;h and uidth) prior to the stress reli~ving step ana a~ter th~ stress rel~ev.lng ct~pl it is preferred that the s~andard de~iation decrease by at least S~6, and more prefera~ly by 5~10%~
For ex2~mple, the standard deviatic~n of the length of 100 sof~gçlæ according to the ~PZ~P formula set fort~
above and b~for~ the stress~rel~ev~ng step was 0.0045 inches. Practic~ng the s.tress relie~;ng s~ep on ~00 2a capsules of the formulati~n referred t~ above ln the temperature xange of 35-3.8~C, at a rel~tive hum~dity o~ 35-45%, and ~or 20 hours,. resulted in the 5tandard de~iation bein~ reduced ~o 0~0042 ~nches, representing a 7.4~ redu~ion.
After the s.tress.reLi~v~ng step~ t~e soft~els are typica~ly brought to rQom tempe~a~ure and ~referably kept at a relative humi~it~ o~ a~out 35-45% in the :
packag~ng oper~tion. Thereafter, ~he softg~ls are placed inta bot~les or blister~packs or another fairly air~igh~ ~yste~ a~;a relati~e ~umidity of about 30-~5%.
~ The present inven~io~ reduces defects ~uch as : dimp~es and b~ bles, provides~a more uni~orm product which facilitates ~ubsequent:operations sush as printîn~ and blister pac~aging, and im~roves shelf li~E
stabili~y resulting from the stress caused by water : loss ~uring dryi~g, gelatin shrinkage and material migration.
.
jW0~3/04674 2 1 1 ~ 7 (~ 7 PCr/US92/074$7 11 .
It will thu~ be seen that the objects set forth above, and those made apparent ~rom the pxeceding description, are efficiently attained. Sinae certain changes may be made without departing from the ~cope of the in~ention, it i~ intended that all matter contained in the abov~ description shall be lnterpreted as illustrative and nok in a limiting sense.
Alternative method~ of heating the capsules may be used to stress r~lieve the ¢apsules resulting i~
shortened proc~s~ing time~. Examples are microwave, ultrasound and infrared radiation~
In addition, t~ presen~ inventiQn i~ not limited to soft~els, but may be u~ed in connect~on with o~her substances haYing bubbles or dimples where suah substances are at least ~reathable and preferably diffu~ible by water.
.
~: :
l~he need ~or ~ncapsulation o~ liguids, ~smi-601i~, 10 and pa~tes within a gelatin shell in su¢h a way as to preclude uncontrolle~ leakage ha~ resultea in the developmsnt of a ~ery fundamental dosage form: ~he so~t g~latin capsule. ~he ~irs~ ~ersion was developed in the middle o~ the l9th cent~ry~ While an ardu~us and no~ particularly accurate proce~s lnitially, current manu~acturi~g proc~sses are fully automated, with a high de~ree o~ prea~sion~
Th~ softgel ~the currently acaepted nom~nclature ~: . adopted by the So~tGel ~ssociation~ is a one-piece~
2:0 . hermetica:lly sealod soft gel~ati~ shell containing a liquid, a suspension, or a ~emi-solid. Y
The mos~ common modern manu~act~rîng process involved in th~ p~paration~of so~tgels is a~aantinuous : methiod whereby two gelatin r~b~ons pa~s ~etween twin 25: : rotating dies. As th~ ribbons m~et, the l~quid to ~e ncapsulatea is~pr~cisely:injected betwe~n ~hem. The : capæule hal~es~are seal~d~and~e~e~ted by the eiontinuous ~; rotation of the::dies. See~P.;Tyle/ SPecialized Druq : DeliverY SYste~s,:;Narcel:Dekker, Inc. (~g90). for a ` 30 genera~l discussion~:of softgel manufac*uring`and : prod~ction~techn~logy, in:~particular, Chapt~r 10 by ~:~: Paul ~.;Wilkinaon~and Foo;~Song Hom.
Various ge~atin:s~ell~masses~may~be prepared, `~` depending on the ~ill proper~ies, climatici condi~ions, 35 ~ and en uGe. Typically gelatin~formulations include the came basic~ingredien~s,~:namely,~ gelatin, a :
5~TITI~T~ FT
1~'JO 93/04674 2 i 1 ~ 7 8 7 Pcr/~sg~/~748 2 r pla;tici~er such as glycerin" water, ana optionally pre~ :e:r~ratives . The formulations of gelatins are well lcnown to those of ordinary sXill in the art.
:t:n most cases, the typica~ rotary dle proces.
,,~
5 requires a ~lowable liguid or f ill . The f ill may be a ~;ingle phas~ uid ac~i~e, a mi~ure of mi~scible liguidcr or a ~ol~ion or a ~uspension o~ ~olids and li~Euids. ~;enerall~ ~e fill contain g~cerin ~nd a medicamellt~ The liquids to be encapsula*ed in a 10 g~l~tin ghell are a~so well l~nc)wn to tho~e af ordinar~
skill in the art.
Shell and flll formulations are dis.cussed in Van Hostetler and J.Q. Bella~d no~ed below as w811 21S in "~d~rances in So~tgel Form~ation ~echnology", I~.S.
~ P~tel, F~S~rS~I Morton a~d~I. S.eager, N~nu~acturing Chemists,. July ~9~9; "So~ Elastic Gela~in Capsules:
~n~que Dosage ~orm", William R~: Ebert, P~armaceutical Techn~logy~ October 1977; "So~t gelatin capsules: a : 601ution to ma~ ~able~ng problems", H. Seager, 20 Pharmaceutical Techno~ogy, Sep~mber 1985; United ; Sta~s Pate~t Na. 4,06.7,960 to Fadda; Un~ted S~ates Pa~ent No. 4,198,3~1 to Grai~ger; Uni~ed S~ates Pa~e~t No. 4r~44r~8~. to ~ro~; and United States Patent No.
780r316 to Brox.~ ~hese re~erences are ~naorporated :2~ . herein b~ this referen~e~
ter the rDtary d~e~pr~ces~s is used ~o thereby : produ~ge~a~n~she~ s~hàvin~ ~ medicam~n~ fil~
therein, the resul~n~ capsules are typically washed wit~ an evaporatable solvent.~ ~hereaPter, the ¢apsules are t~pically tumble~drie~:in ~ series o~ hollow drum5 wi~h`perforate~ wa~ls- Hea~ed dr~ air i5 con~inuously : p~mpe~ throug~ ~he~rotating drums at an air tem~erature : typiaally l~ss than:35C.~ T~e war~1r being blown into:~e aapsules~appear~ :penetrate ~e shell a~d cauæe~t to dry from the ~nside by~m:o~ing t~e water ~: outward to the surfaae of the~capsule. By the time t~e : capsules exi~ this`process, all of the ~olvent used in . . :
:
:
~ ,W093/04674 2 ~ 1 ~ 7 8 7 PCT/VS92/07487 3.
washing has typically been evaporated, and a large proportion (50-60%) of the water from the gelatin shell haq ~een removed. Recent developments in drying include bypa~sing ~he drum drying stag~ and having the aapsules dried in a drying tunnel or room as discuss~d below~
After the capsules exit the la~t drying drum, the aapsules are typically ~pread on drying trays. The ~inal drying pha~ ~or softyels is ~ypically acc~mplished ~.,pa~sing the drying trays through drying tunnels or in~o drying rooms~ Stacks o~ trays are inserted ~nto drying tunnels or drying ro~m~, in which controlled temperatur~ air ~21-24~C~ ~nd 1QW relative humidity ~20-30%) i~ continuously circul~ted. Although additional water may ~e remo~ed ~rom dxy capsules by further heating, ~or example a~ 40C, such a procedure has not been found to b~ prac~iaal or necessary. See Van ~05t~tler and J.Q. Bellard in The ~heory and Practice o~ Industrlal Pharmacy, "Capsules~', (1970), Chapter ~3 at pa~s 346-383, and in particular at page 380.
: The drying time, for most softgel~, is 16-24 hours, but may be slightly longex i~ the qo~tgels arç over 20 minims in ~ize or i~ the 50~tg~1s contain a non-o~ly typ~ liquid base.
Softgels per~itted ta~ come to water equilib~ium in this aontrolIéd enviror~snt are considered "dry". ~rhe gQlatin f ~11 and shell of suc~ "dry" sof~gels con~ain 6-10% wa~er depending on the ~pecific ~elatin and fill 30 f~rmula used.
' I P~fter q:rying, t:he capsules areitypically insp cted and ~inished using varied lcnown tec:hni~ues.
~ ' ~
:: 3. The Proklem~and Obiects o~ the ~nvention ~5 D~spite well known manu~acturing proc~sses for softgels, a nu~ber of significant problems exist.
During the inspection step, it is yuite common to ~ind ` : :
~?VO g3/04674 2 :~ 1 9 7 8 7 PCI/US92/07487 4.
so:~tgels ha~ring dimples in the shell and bubbles in the I~ill. q?he dimples and bubbles are unsightly in appearance and reduce the o~rerall quali~y o~.the 50ft~el batch. Thus those de~ect~ ve ~30ftgel~ must be 5 rej ected or thro~ away ~. Cor~se~uent~ as a resul-t o:e ~;uc:h ~ples and bubbles, softgel pro~uct:ion ef$ic:ien~y is decreased~
Moreo~e:r it is highly desired that the sc?f~ge manufacturing proc~sE~ result in a batch of~
10 dimensicnally uni~or~ so~gel~. ~pically uni~ormity o~ a softgel i8 measured by the standard dev~atlon in ~e ~enç~thwise and wid~hwise measurement o~ an oblong $o~tgel or th~ diameter o~ a r~nd sof~gel. ~lthough atte~pts have been made to produce more dimensioIlally 15 un~orm prod:u¢ts, for example, produa~s having a reduced dimensional s*andard d~iation, 130ftgels prot~uced a~ter typ~ca~ drying processes often result in an unacaepta~le standard deviation.
It is thereore an object o~ the present inven~ion ~0 to pro~ide a 50f~g~1 manufacturing process which results i~ softgel products having a minimal ~olume and num~er of dimples;and bukbles, and w~ic~ ~re rela~ively aimensionally:unifonm~
~:~ 2~ ~pNakY OF ~HE D ~ SURE
Th~ pro~ems of di~ples, ~ubble~ and pr~duct d ~e~sion~l uniformity ~a~e~been greatly reduc~d by the present invention ~hich~is a ~igni~icant advance in ~he art of so~tgeI~;ma~facturing:proce~ . The inventors ~a~Q di~cov~ere~ at by~sub~e~ting '~dry'l ~o~gel~ to ~
' subs~guent1~*ress rellcving step, the volume ana number : of defects s~h~as dimp1es~and bubb}es exi~ting în ~he : sof~gQ~s pr~or:to the stress rel~e~ing step can be su~s~an~ially ~educ~d. In addikion, the stress ~ 35 relie~ing st~p;reduGes dimensional s~andard de~ia~ion : ther~by resulting in more~dimensionally unifo~m batGhes of softgels~ ~
:~ .
W093/0~674 2 1 1 ~ 7 8 7 PCT/US92J07487 ~. , The stress relie~ing step comprises subjecting the "dry" capsules to a subsequent heating step at a heightened temperature and relati~e humidîty. By subjecting the "dry" softgels to this step, dimpl~s and ~ubbles ~re removed ~rom the softgels and the dimensional standard deviation is pre~erably reduced.
Brie~ ~escri~tion o~_the Fiqures Fig. 1 is a schemati~ ~howing the s~ress r~lieving or tempering room.
Figs~ 2~ and B are ~f~r~ and a~ter phatograph~ of o~tgels sub~ected to th~ str~s5 relieving ~kep.
~, DET~LIIJED DESC~IPTION OF TH~ ~EF~D EMsoDIMENq!s Sc)ftgel~; are genQrally prep~r2d 3~y enc~psNl~ting a medicated f ill in a gelatin shell .. The shells and fills are pr~pared acaording to go~mulations w~ll known to those o~ skill in the art. For example, a typical gelatin shell formulation might inGlude ~by weight):
Gelatin 47%
:~ Glycerin, USP~ 15%
Water 38%
+ Colors~
. .
~he shell oan be ~illed by ~tandard encapsulation teahniques with a variety~:of ills including PEG and propylene glycol. ~ ~
30 ~ A~ypical hygroscopic medicated fill might include ! ' ' (by weight)~
` ~ : :; `
ACTIVES: ~Acetaminoph~n (APAP) (250 mg~ 27~
~ P~eudoephedrin HCl (30 mg) 3%
: 35 Dextromethoxphan~Br ~15 mg) 1.6%
Doxylamine Succinat~ (6.25 mg) .6%
; X~ACTIVE: Polyethylene Glycol (PEG) 67.8 :
:: :
wo g3/04674 ~ 7 ~ 7 PCI/US92/07487 6.
Although the example above uses a hydrophilic f ill, other ~ill5 are within the æcope of the pre~;ent in~re~on. Tn addition, the P}~G can be PEG 400 or a PEG of higher molecul~ar weight. Eurther, th~ use of 5 sorbitol ~ree shell~; appear~ to facilitate the st:ress relieving ~:tep.
~ rhe softgelt; can be encapsulate~l using known fill~
and shell~; by t~chTligues kno~m to thos~ o~ ~kill in the art, for ex~mp Q~ eithe~ t~e plate method or ~he 10 con~inuous rotati~ die methods ~e~cribed pre~iousl~.
~ ter the encapsulatioll and wash~ng steps, the resultlng capsules are typically dried ~n drying tunnels or rooms for.2tbc~ut 3-7 da~Ts ~o remove ~a~er in the hys~roscopic fill and the shell to abou~ 6~% by 15 volume.. ~hese are t~ ally call~d "d:ry" capsules.
T~e g~rl Fischçr tes~ is used for determinirlg water content~ Th~ drying oc:curs t~ically at about 21~-249C
and at a rela*i~re h~m;idity o~ 20-~0%. One can llse infrared rad~at:ios~ ~o dr~ ou~ the wate~ as an 2.0 alternati~re.
~ e amolmt o~ time the capsules are in the drying ~unnels or room depends o~ t~e thickness of the gala~in shell, ~he a~ount o~ oll o~ the surface of the gel after t~e ~ashin~ st~, tb,e :densi~y o~ .capsules on the 2$ trays~ and other fac~Drs. kTwwn to ~hose of ordinary sJ~i~l in th~ art.
A~er t~e cap~sules ar~ t they are sub~e-c~ed ~o the nov~l step of t~e presen~ inve:~tion, namely a stress relieving step.
~he s~ress relieving step is als~ referred ~o hereln as a su~se~uent h~a~in~{ step or a ~empering step . In general ,: the stress relieving step lnvolves a change in th~ conai~:ions o~temperature and relati~re humidit~ f~rom ~he drying ;step.~ By changing the condit~ons of ~emperature~ and relative humidity, dimpl~s in the shell ~nd bub~les i~ the fill are .
... W093/04~74 . 2 1 1 9 7 8 7 PCT/US92~07487 7.
substantially removed. In addition, the product preferab~y becomes more dimensionally uniform.
The stre~ relieving ~tep can take plae in the same tunnel's or drying rooms or tempering rooms as the priox drying s~ep, and thus no new eguipment or additional labor is required. ~oreover, the stress relie~ing step can-be ~caomplished in the continuum o~
the d~ing st~p. For example, cap~ules could be dried ~or three day5 in drying tunnels and ~ubsequently ~0 8tre~s relieved with elevated temperature an~ humidity conditicns~ In suah case, the bubbles and dimples would not be o~erv~d. ~hi~ is due to the fact that drying continues during the time period that the p~oduct is in the tempering room.
With re~er2nce to Figure 1, there is shown in block layout ~orm an iIlustrativ~ and pre~erred air conditioning sy8tem for inspection rooms 10 and a tempering room 20 whi~h can selectively maintain 21~
43~ and 35-60% rel~ti~e humldity. The tempering r~om can be used ~or the~.drying and:s~ress relie~ing steps.
As can be seen fr~m th~ block layout there is one : 7~ ton heat pump 30 with a second unit (not shown) as a back up, a humidi~ier 40, two l~KW duct strip heaters 50, and one 15KW: ~uct heatex 60 for supplying air to eacll room. Also th~ te~pering room 20 has six 3000 CE~
blower fans 70 mounted at one end o~ the tempering room for circulating ~room air and a filter banlc e~aust (not shown) at the ol?posite: ~nd of the room. Each room is also supplied with ia temperature thermostat (no~ shown) that control~ the~duct ~trip ;hea~ers. There i~; a humidistat l(nc~t shown) mounted in the tempering room which controls the humidifie~ 40.
~he degree ~o:which:de~ects such as dimples i~nd bubbl~s are remo~ed can be mea~ured by considering the :35 number and v~lume of dimples and bubbles prior to the : stress r~lie~ing step as~compared to the number and volume foll~win~ the stress relieving ~tep. Figures 2A
~ W~ ~3/04674 2 1 ~ .~ 7 ~ 7 PC~/US9~/074~7 8.
and B axe photographs of a ba~ch of softgels before the ~tress relieving or tPmpering step and therea~ter.
Th~ so:~gel capsules shown had the following formulati~n (l~y we~ght):
Shell: Gelatin 47%
Giyaerin 15%
Water 3~ (plus color~ng agent and be~s:)re dr~,ring S~QP) Fill: PQ~ hY1ene Gl~col ~Q0% (920 mg) One hundxed capsules were placea on a coun~ing tray 15 after l:eiTIg me2Lsu:~ed indivi~all~"rc The~3e c~psules were preY~ousl~ dried ~Eor nine days to a water c~nten~ ":e 7.9% under cond~ions of 27.~ rela~i~e hum~d:3~y a~sd 24C
to thereby conq~i~u~e "d~y" softgels.
As i~dicated ~by t:he before pho~o~raph: in Fig~re 2A;, ;20 all of the capsules con~ained bubble~. The~e capsul~s wsre ~:tres5 r~lie~ea at 35C and 45% rela~ive humidity for 20 hou~s, and: then re-photograph~sd as sho~n in Figure 2~. As c~n l~e séen~ all ~ubbles ~l~h ~he exca~ on oi~ two were ~liminated and the d~ensional 2~$ ~aria~n of the cap~ul es wa~ re~d. That iF;, k~e s~andard d~ation of 'che length was reducea ~rom Q.t~0458 i~o 0.û-042~ inch~s and o~ ~:he ~i~th :~ro~ 0.0036 to 0 . 0033 ~ hes ~ : .
~hese $ame capsul~s were returned to ~he tempering 30 room i~or an ~ddi~ional 20; hours~ Af~r the second tempering:, no bu~bles~ remained.
q~he pr~:3e~t inven~ t~nded ~o decrea5e -~he vol~e o ~limples and: bubbles b~ at least preferabl~ by 5096, more pre~er~ly ~y at l~ast 75%, an~
35 opti:mally b~ 9~ 0%~ ~rhe decr2ase in ~i~ples and bubbles can readily be ~isually saen during ~nspection ' ' ~ .
, ,. ,,wo g3/04674 Pcr/vss2/074g7 of the softgels before and after the ~tress xelieving step .
Generally, the stres~ relieving step is accompli~hed at a temperature within the preferred range of 32 and 38~C. It is possible to ~tres~
relieve the capsule~ at a temperature above ~3C
depending upon the fill and gelatin formula~ The temperature should not be so hi~h such khat the capsules w~uld melt. 43C is generally at the high end, although preferably the high end i~ 3BC.
On ~he other hand, the temp~rature range at the low end i5 pre~erably a~o~t 35C~ I~ the tempera~ure is.
much lower than 35ac, the ~tress relie~ing may not b~
adequate or else the stress relieving step may ta~e an undesirable and impractical length of time.
Thu~, in general, it is pre~erable that the temperature of the drying tunnel~ or drying rooms during the stress relieving~step range fxom ~o to 43C, and more pre~erably from 35 to 38C.
Dur~ng the ~tre~ reli~ving step,.it is also important that the relative humidity within the tunn~ls or te~pering room xange ~rom about 35~ ~o a~out 60%, preferably 35-4~5%, and optimall~ 40-45%. Employin~
this relative hu~idity range, coupled with the heightened tempe~ature, un~xpect~dly provides ~o so~tgel batches ~he long needed increase in topological ~ ana dimensional uniformity.
: The hum~d~ty range is m~an~ to match th~
equilibrium relati~e humidity (E~H) of the ~apsules.
I~ the tunnel or tempering room relative humidity is .. below 35%/ exaessive drying~may ocour. If the relati~e humidity is abo~e 60%,:water may b~e added t~ the gelatin and fill~ resulting in a poor product.
From a gener~l standpoint, the stress relieYing æt~p wiIl be at that~temperature, relati~e humi~ity and for that time period:tbat will remove substantiall~ all ~ 93J0~674 2 1 ~ 7 ~ 7 PCr/US92/07487 10 .
dimples and ~u~bles, and pr~erably tha~ will minimize dlmen~;ional ~;tar~dard deviation.
Generally, the str~ss relieving step will take at least one h~ur, p~e:erab~ at least two hours. The general rang~ is about 1 ~o 7S hours, although over 75 hours is wi~hin t~e s~ope o~ the present invention.
q!he process of ~:he present in~ention i~ also charac~exizea by ~proving the consistency or ~i~o~mi~y of t:~e softgel~ and reducing. the stand~rd de~riation of ~e softgel dim~nsions. When c~?mpa~ing the standard dev~:a~ion o~ the soft~el d~mensions.
(leng~;h and uidth) prior to the stress reli~ving step ana a~ter th~ stress rel~ev.lng ct~pl it is preferred that the s~andard de~iation decrease by at least S~6, and more prefera~ly by 5~10%~
For ex2~mple, the standard deviatic~n of the length of 100 sof~gçlæ according to the ~PZ~P formula set fort~
above and b~for~ the stress~rel~ev~ng step was 0.0045 inches. Practic~ng the s.tress relie~;ng s~ep on ~00 2a capsules of the formulati~n referred t~ above ln the temperature xange of 35-3.8~C, at a rel~tive hum~dity o~ 35-45%, and ~or 20 hours,. resulted in the 5tandard de~iation bein~ reduced ~o 0~0042 ~nches, representing a 7.4~ redu~ion.
After the s.tress.reLi~v~ng step~ t~e soft~els are typica~ly brought to rQom tempe~a~ure and ~referably kept at a relative humi~it~ o~ a~out 35-45% in the :
packag~ng oper~tion. Thereafter, ~he softg~ls are placed inta bot~les or blister~packs or another fairly air~igh~ ~yste~ a~;a relati~e ~umidity of about 30-~5%.
~ The present inven~io~ reduces defects ~uch as : dimp~es and b~ bles, provides~a more uni~orm product which facilitates ~ubsequent:operations sush as printîn~ and blister pac~aging, and im~roves shelf li~E
stabili~y resulting from the stress caused by water : loss ~uring dryi~g, gelatin shrinkage and material migration.
.
jW0~3/04674 2 1 1 ~ 7 (~ 7 PCr/US92/074$7 11 .
It will thu~ be seen that the objects set forth above, and those made apparent ~rom the pxeceding description, are efficiently attained. Sinae certain changes may be made without departing from the ~cope of the in~ention, it i~ intended that all matter contained in the abov~ description shall be lnterpreted as illustrative and nok in a limiting sense.
Alternative method~ of heating the capsules may be used to stress r~lieve the ¢apsules resulting i~
shortened proc~s~ing time~. Examples are microwave, ultrasound and infrared radiation~
In addition, t~ presen~ inventiQn i~ not limited to soft~els, but may be u~ed in connect~on with o~her substances haYing bubbles or dimples where suah substances are at least ~reathable and preferably diffu~ible by water.
.
~: :
Claims (25)
We claim:
1. In a process for producing a plurality of shell filled bodies, wherein the fill is first encapsulated in a shell and then the shells containing the fill are dried so that the water content of the shell ranges from 6-10%, the improvement comprising heating the filled shells at 32°-43°C and at 35-60% relative humidity whereby dimples and bubbles are removed from the filled shells.
2. The process according to claim 1 wherein the heating is accomplished at a temperature range of 35°-38°C.
3. The process according to claim 1 wherein there are a plurality of oblong filled shells and the standard deviation of the filled shell lengths and widths after the subsequent heating step has decreased.
4. The process according to claim 3 wherein the standard deviation has decreased by at least 5%.
5. The process according to claim 1 wherein the bodies are softgels and the fill is hygroscopic.
6. The process according to claim 1 wherein the subsequent heating step occurs for a time period sufficient to remove substantially all dimples and bubbles.
7. The process according to claim 6 wherein the time period is at least 1 hour.
8. The process according to claim 7 wherein the time period ranges from 1 to 75 hours.
13.
13.
9. The process according to claim 8 wherein the time period is about 2 hours.
10. The process according to claim 6 wherein over 95% of bubbles and dimples existing prior to the stress relieving step are removed.
11. The process according to claim 1 wherein the shells are one-piece, hermetically sealed soft gelatin shells.
12. A process for producing softgels, the process comprising the following steps:
encapsulating a fill in a shell to form filled capsules;
drying the resulting capsules; and thereafter stress relieving the resulting capsule to thereby remove defects in the shell and fill that were in the shell and fill prior to the stress relieving step.
encapsulating a fill in a shell to form filled capsules;
drying the resulting capsules; and thereafter stress relieving the resulting capsule to thereby remove defects in the shell and fill that were in the shell and fill prior to the stress relieving step.
13. The process according to claim 12 wherein the drying step occurs at a relative humidity of 20-40% and the stress relieving step occurs at a relative humidity of 35-60%.
14. The process according to claim 13 wherein the drying step occurs within a temperature range of 21°-24°C and the stress relieving step occurs within a temperature range of 32°-43°C.
15. The process according to claim 14 wherein the stress relieving step occurs at a temperature within the range of 35°-38°C.
14.
14.
16. The process according to claim 12 wherein there are a plurality of filled shells and the standard deviation of the filled shell lengths and widths after the stress relieving step has decreased by at least 5%.
17. The process according to claim 16 wherein the fill is hygroscopic and the drying and stress relieving step result in capsules having 6-10% by volume water in the shell.
18. The process according to claim 17 wherein the shell is sorbitol free.
19. The process according to claim 12 wherein the stress relieving step occurs for a time period sufficient to remove substantially all dimples and bubbles.
20. The process according to claim 19 wherein the time period is at least 1 hour.
21. The process according to claim 20 wherein the time period ranges from 1 to 75 hours.
22. The process according to claim 21 wherein the time period is at least about 2 hours.
23. A process for improving topographical and dimensional uniformity of softgels, the process comprising increasing the temperature and relative humidity after initiation of drying of the softgels.
15.
15.
24. The process of claim 23 wherein the temperature is above 32°C and the relative humidity is above 35%.
25. The process of claim 23 wherein the volume of bubbles and dimples in the softgels has decreased by at least 25% when comparing the volume before and after the softgels are subjected to the increased temperature and humidity.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US757,553 | 1991-09-11 | ||
US07/757,553 US5200191A (en) | 1991-09-11 | 1991-09-11 | Softgel manufacturing process |
PCT/US1992/007487 WO1993004674A1 (en) | 1991-09-11 | 1992-09-04 | Softgel manufacturing process |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2119787A1 true CA2119787A1 (en) | 1993-03-18 |
Family
ID=25048266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002119787A Abandoned CA2119787A1 (en) | 1991-09-11 | 1992-09-04 | Softgel manufacturing process |
Country Status (5)
Country | Link |
---|---|
US (1) | US5200191A (en) |
AU (1) | AU2575092A (en) |
CA (1) | CA2119787A1 (en) |
MX (1) | MX9205169A (en) |
WO (1) | WO1993004674A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376688A (en) * | 1992-12-18 | 1994-12-27 | R. P. Scherer Corporation | Enhanced solubility pharmaceutical solutions |
DE69435104D1 (en) | 1993-09-28 | 2008-07-31 | Scherer Gmbh R P | Production of soft gelatine capsules |
EP0935111B1 (en) | 1998-02-05 | 2003-05-21 | SWISS CAPS Rechte und Lizenzen AG | Process and apparatus for drying soft biopolymer capsules, in particular soft gelatin capsules |
US20050037065A1 (en) * | 1999-05-27 | 2005-02-17 | Drugtech Corporation | Nutritional formulations |
US6346231B1 (en) * | 1999-10-06 | 2002-02-12 | Joar Opheim | Flavored gelatin capsule and method of manufacture |
US7122143B2 (en) * | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
MXPA04002980A (en) * | 2001-09-28 | 2005-06-20 | Johnson & Johnson | Dosage forms having an inner core and outer shell with different shapes. |
US6982094B2 (en) * | 2001-09-28 | 2006-01-03 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
US7217381B2 (en) * | 2001-09-28 | 2007-05-15 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
US6837696B2 (en) * | 2001-09-28 | 2005-01-04 | Mcneil-Ppc, Inc. | Apparatus for manufacturing dosage forms |
US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
US6767200B2 (en) | 2001-09-28 | 2004-07-27 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
US6742646B2 (en) * | 2001-09-28 | 2004-06-01 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
ES2327034T3 (en) | 2002-03-26 | 2009-10-23 | Euro-Celtique S.A. | COMPOSITIONS COVERED WITH SUSTAINED RELEASE GEL. |
US7169450B2 (en) | 2002-05-15 | 2007-01-30 | Mcneil-Ppc, Inc. | Enrobed core |
US6946156B2 (en) * | 2002-05-15 | 2005-09-20 | Mcneil-Ppc, Inc. | Process for enrobing a core |
ATE487470T1 (en) * | 2002-09-11 | 2010-11-15 | Elan Pharma Int Ltd | GEL-STABILIZED ACTIVE COMPOSITIONS IN NANOPARTICLE SIZE |
US7807197B2 (en) * | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
US20050074514A1 (en) * | 2003-10-02 | 2005-04-07 | Anderson Oliver B. | Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms |
US7404708B2 (en) * | 2004-12-07 | 2008-07-29 | Mcneil-Ppc, Inc. | System and process for providing at least one opening in dosage forms |
US7530804B2 (en) * | 2004-12-07 | 2009-05-12 | Mcneil-Ppc, Inc. | System and process for providing at least one opening in dosage forms |
US8673352B2 (en) * | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US20090004231A1 (en) | 2007-06-30 | 2009-01-01 | Popp Shane M | Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring |
US20090214641A1 (en) * | 2008-02-26 | 2009-08-27 | Joar Opheim | Sweetened Capsules for Administration |
US8621764B2 (en) | 2011-03-16 | 2014-01-07 | John PUCKETT | Gelatin capsule formulation and drying system |
US20160022594A1 (en) * | 2013-03-15 | 2016-01-28 | Russell Jaffe | Soft gel encapsulation |
WO2015195990A1 (en) * | 2014-06-20 | 2015-12-23 | Banner Life Sciences Llc | Liquid-filled immediate release soft gelatin capsules |
BR112018073949A8 (en) | 2016-05-25 | 2023-03-21 | Tsi Group Ltd | GELATIN CAPSULE AND METHOD FOR FORMING A GELATIN CAPSULE. |
RU2745334C9 (en) * | 2016-12-08 | 2021-05-24 | Р.П. Шерер Текнолоджис, Ллс | Drying soft capsules in a controlled medium on an accelerated basis |
US11583552B2 (en) | 2021-02-17 | 2023-02-21 | Manoj Maniar | Pharmaceutical formulation of arsenic trioxide |
CN117693330A (en) * | 2021-03-17 | 2024-03-12 | 普鲁克普斯股份有限公司 | Prefill system for eliminating air bubbles in capsules having solid dosage forms |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2851786A (en) * | 1955-04-18 | 1958-09-16 | Scherer Corp R P | Method for drying gelating capsules |
US4198391A (en) * | 1973-07-20 | 1980-04-15 | R. P. Scherer Ltd. | Pharmaceutical compositions |
US4067960A (en) * | 1975-06-20 | 1978-01-10 | R. P. Scherer Limited | Pharmaceutical compositions containing cardiac glycoside |
US4166800A (en) * | 1977-08-25 | 1979-09-04 | Sandoz, Inc. | Processes for preparation of microspheres |
DE3307353C2 (en) * | 1983-03-02 | 1985-01-31 | R.P. Scherer GmbH, 6930 Eberbach | Soft gelatin capsule containing polyethylene glycol and process for their production |
GB8305693D0 (en) * | 1983-03-02 | 1983-04-07 | Scherer Ltd R P | Pharmaceutical compositions |
US4816259A (en) * | 1987-02-12 | 1989-03-28 | Chase Chemical Company, L.P. | Process for coating gelatin capsules |
JPS63258641A (en) * | 1987-04-16 | 1988-10-26 | Suntory Ltd | Manufacture of microcapsules |
GB8721455D0 (en) * | 1987-09-11 | 1987-10-21 | Lilly Industries Ltd | Capsules |
US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
-
1991
- 1991-09-11 US US07/757,553 patent/US5200191A/en not_active Expired - Fee Related
-
1992
- 1992-09-04 AU AU25750/92A patent/AU2575092A/en not_active Abandoned
- 1992-09-04 WO PCT/US1992/007487 patent/WO1993004674A1/en active Application Filing
- 1992-09-04 CA CA002119787A patent/CA2119787A1/en not_active Abandoned
- 1992-09-10 MX MX9205169A patent/MX9205169A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2575092A (en) | 1993-04-05 |
US5200191A (en) | 1993-04-06 |
MX9205169A (en) | 1993-05-01 |
WO1993004674A1 (en) | 1993-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2119787A1 (en) | Softgel manufacturing process | |
FI83391C (en) | PARTICULARS TO BE INCLUDED IN THE PARTICULARS. | |
KR20010033605A (en) | Gelatine Compositions | |
ES2240148T3 (en) | COMPOSITIONS IN PULULANO FILM. | |
KR100194241B1 (en) | Pharmaceutical forms and other dosage forms | |
CN107361392B (en) | A kind of three layers contain capsule with diuresis promoting function and preparation method thereof | |
US5254294A (en) | Soft gelatin capsules | |
RU2070029C1 (en) | Carrier for remedy for retaining it in stomach | |
FI77155B (en) | FOERFARANDE FOER FRAMSTAELLNING AV EN FAST FORMAD ARTIKEL. | |
US5188688A (en) | Method of sealing a gelatin capsule | |
CN101534803A (en) | A method of administering a film product containing a drug | |
FR2326281A1 (en) | METHOD AND APPARATUS FOR THE MANUFACTURE OF ORIENTATED PLASTIC HOLLOW ARTICLES | |
IT1050260B (en) | PROCEDURE FOR THE PRODUCTION OF A BIODEGRADABLE POLYESTER RESIN AND PRODUCT OBTAINED IN PARTICULAR IN THE FORM OF SUPPORT CAPABLE OF SELLING SUBSTANCES IN A CONTROLLED WAY OF SUTURE AND BANDAGE WIRES | |
CN101321511A (en) | Topical film compositions for delivery of actives | |
JPH07145040A (en) | Dehydrated liposome | |
EP0401832A3 (en) | Method for preparing hard capsules for medicaments | |
RU2240768C2 (en) | Capsule | |
US2491475A (en) | Enteric capsule | |
US7744945B2 (en) | Method of tablet enrobing | |
ES2602571T3 (en) | Band sealing element for hard capsules with PEG encapsulated therein | |
BR112014000151B1 (en) | METHOD FOR PRODUCING A CONFECTIONERY PRODUCT | |
CN106643006A (en) | Freezing and drying preparation method and application of pomelo fruits | |
CA1063024A (en) | Preparations containing n-(2-furfuryl)-4-chloro-5-sulfamoylanthranilic acid and process for their manufacture | |
EP1535595A1 (en) | Process for producing aspheric seamless capsule and apparatus therefor | |
CA1289074C (en) | Process for producing individually dosed administration forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |